VACCELERATE is a pan-European clinical research network established to accelerate vaccine trials and pandemic preparedness. Funded by the European Union under the Horizon 2020 program, the project aimed to streamline and harmonize clinical trial efforts across Europe, facilitating rapid access to trial sites, expert teams, and standardized protocols.
Key aspects of VACCELERATE include:
- Building a clinical trial network across Europe and associated countries
- Expediting (vaccine) research by coordinating trials efficiently
- Engaging the public through initiatives like the Volunteer Registry to increase participation in clinical studies
- Harmonizing data collection to improve research quality and comparability
- Providing training and capacity-building for clinical researchers
- Investigating vaccines in under-researched populations (e.g., children and the elderly)
Although the EU funding for VACCELERATE has ended on 27 January 2025, the established infrastructure and collaborations are expected to continue supporting future (vaccine) research and public health initiatives.
Questions? Remarks? Contact us: info@vaccelerate.eu.
Social media updates after 27 January 2025 on https://bsky.app/profile/olivercornely.bsky.social and https://www.linkedin.com/in/oliver-a-cornely-7859b747/.